Cargando…

STAT6-mediated BCL6 repression in primary mediastinal B-cell lymphoma (PMBL)

Primary mediastinal B-cell lymphoma (PMBL) is characterized by aberrant activation of JAK/STAT-signaling resulting in constitutive presence of phosphorylated STAT6 (pSTAT6). In primary PMBL samples pSTAT6 is only expressed in a sub-population of lymphoma cells in a pattern that is reminiscent of tha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ritz, Olga, Rommel, Karolin, Dorsch, Karola, Kelsch, Elena, Melzner, Julia, Buck, Michaela, Leroy, Karen, Papadopoulou, Vasiliki, Wagner, Simon, Marienfeld, Ralf, Brüderlein, Silke, Lennerz, Jochen K., Möller, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2013
Materias:	Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759668/ https://www.ncbi.nlm.nih.gov/pubmed/23852366

Ejemplares similares

Targeting STAT6 in PMBL
por: Leroy, Karen, et al.
Publicado: (2014)

Double-punching PMBL
por: Lennerz, Jochen K.
Publicado: (2014)

Knock-down of BCL6 / STAT6 sensitizes primary B cell lymphoma cells for treatment with current therapeutic agents
por: Häberle, Marie-Therese, et al.
Publicado: (2014)

Targeting the intratumor heterogeneity in PMBL
por: Ritz, Olga, et al.
Publicado: (2014)

Transformation of FL into DLBCL with a PMBL gene expression signature
por: Loveday, Tristan, et al.
Publicado: (2022)

KIT mutations in primary mediastinal B-cell lymphoma
por: Nagel, P D, et al.
Publicado: (2014)

Bcl-6 directly represses the gene program of the glycolysis pathway
por: Oestreich, Kenneth J., et al.
Publicado: (2014)

Obinutuzumab (GA101) vs. rituximab significantly enhances cell death, antibody-dependent cytotoxicity and improves overall survival against CD20+ primary mediastinal B-cell lymphoma (PMBL) in a xenograft NOD-scid IL2Rgnull (NSG) mouse model: a potential targeted agent in the treatment of PMBL
por: Chu, Yaya, et al.
Publicado: (2020)

IL-7 signalling represses Bcl-6 and the T(FH) gene program
por: McDonald, Paul W., et al.
Publicado: (2016)

The Ansamycin Antibiotic, Rifamycin SV, Inhibits BCL6 Transcriptional Repression and Forms a Complex with the BCL6-BTB/POZ Domain
por: Evans, Sian E., et al.
Publicado: (2014)

Repression of BCL-6 is required for the formation of human memory B cells in vitro
por: Kuo, Tracy C., et al.
Publicado: (2007)

Loss of Transcriptional Repression by BCL6 Confers Insulin Sensitivity in the Setting of Obesity
por: Senagolage, Madhavi D., et al.
Publicado: (2018)

FOXO1 downregulation contributes to the oncogenic program of primary mediastinal B-cell lymphoma
por: Xie, Linka, et al.
Publicado: (2014)

Dynamic repression by BCL6 controls the genome-wide liver response to fasting and steatosis
por: Sommars, Meredith A, et al.
Publicado: (2019)

High-Grade B-Cell Lymphoma (HGBL) with MYC and BCL2 and/or BCL6 Rearrangements Is Predominantly BCL6-Rearranged and BCL6-Expressing in Taiwan
por: Tsai, Cheng-Chih, et al.
Publicado: (2021)

BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia
por: Hurtz, Christian, et al.
Publicado: (2011)

BCL6 positively regulates AID and germinal center gene expression via repression of miR-155
por: Basso, Katia, et al.
Publicado: (2012)

Cortical Neurogenesis Requires Bcl6-Mediated Transcriptional Repression of Multiple Self-Renewal-Promoting Extrinsic Pathways
por: Bonnefont, Jerome, et al.
Publicado: (2019)

Lymphocytes of Type 2 Diabetic Women Carry a High Load of Stable Chromosomal Aberrations : A Novel Risk Factor for Disease-Related Early Death
por: Boehm, Bernhard O., et al.
Publicado: (2008)

Making memories with Bcl-6
por: Read, Kaitlin A., et al.
Publicado: (2021)

Expression and Y435-phosphorylation of Abelson interactor 1 (Abi1) promotes tumour cell adhesion, extracellular matrix degradation and invasion by colorectal carcinoma cells
por: Steinestel, Konrad, et al.
Publicado: (2014)

Bcl-XL and Bcl-2 repress a common pathway of cell death
Publicado: (1995)

Analysis of the CDK4/6 Cell Cycle Pathway in Leiomyosarcomas as a Potential Target for Inhibition by Palbociclib
por: Böhm, Michael J., et al.
Publicado: (2019)

MKL/SRF and Bcl6 mutual transcriptional repression safeguards the fate and positioning of neocortical progenitor cells mediated by RhoA
por: Cossard, Alexia, et al.
Publicado: (2023)

Molecularly Stratified Treatment Options in Primary Refractory DLBCL/HGBL with MYC and BCL2 or BCL6 Rearrangements (HGBL, NOS with MYC/BCL6)
por: Witte, Hanno M., et al.
Publicado: (2023)

Significance of Bcl-2 and Bcl-6 immunostaining in B-Non Hodgkin's lymphoma
por: Mahmoud, Hanan Mohamed, et al.
Publicado: (2011)

Ezh2 programs T(FH) differentiation by integrating phosphorylation-dependent activation of Bcl6 and polycomb-dependent repression of p19Arf
por: Li, Fengyin, et al.
Publicado: (2018)

Hit-and-run lymphomagenesis by the Bcl6 oncogene
por: Green, Michael R, et al.
Publicado: (2014)

SOCS1 Mutation Subtypes Predict Divergent Outcomes in Diffuse Large B-Cell Lymphoma (DLBCL) Patients
por: Schif, Birgit, et al.
Publicado: (2012)

Description of an Institutional Cohort of Myeloid Neoplasms Carrying ETV6-Locus Deletions or ETV6 Rearrangements
por: Papadopoulou, Vasiliki, et al.
Publicado: (2023)

Therapeutic melanoma vaccine with cancer stem cell phenotype represses exhaustion and maintains antigen-specific T cell stemness by up-regulating BCL6
por: Czerwinska, Patrycja, et al.
Publicado: (2020)

The malignancy suppression and ferroptosis facilitation of BCL6 in gastric cancer mediated by FZD7 repression are strengthened by RNF180/RhoC pathway
por: Guo, Shiwei, et al.
Publicado: (2023)

NAC1 attenuates BCL6 negative autoregulation and functions as a BCL6 coactivator of FOXQ1 transcription in cancer cells
por: Gao, Min, et al.
Publicado: (2020)

The epigenetic regulator CTCF modulates BCL6 in lymphoma
por: Batlle-López, Ana, et al.
Publicado: (2015)

Chronic simian immunodeficiency virus infection is associated with contrasting phenotypes of dysfunctional Bcl6(+) germinal center B cells or Bcl6(−)Bcl2(+) non‐germinal center B cells
por: Onabajo, Olusegun O., et al.
Publicado: (2018)

Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma
por: Dupont, Thibault, et al.
Publicado: (2015)

C-MYC, BCL2 and BCL6 Translocation in B-cell Non-Hodgkin Lymphoma Cases
por: Salam, Dayang Sharyati Datu Abdul, et al.
Publicado: (2020)

TdT Positive Lymphoma with MYC, BCL2 and BCL6 Rearrangements: A Review of Diagnosis and Treatment
por: Singh, Aditi, et al.
Publicado: (2022)

Role of the Transcriptional Repressor BCL6 in Allergic Response and Inflammation
por: Arima, Masafumi, et al.
Publicado: (2008)

BCL6 modulation of acute lymphoblastic leukemia response to chemotherapy
por: Slone, William L., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_s5ecqjpk4u835cnjpd91evrtlb